This Hims & Hers Move Could Destroy Competitors

Hims & Hers (HIMS 8.86%) has had a rough go of it in 2026, but a recent deal with Novo Nordisk (NVO 1.43%) may bring the company’s operations back to life. The Wegovy pill is one of the products coming to Hims & Hers, and we now know details of what that launch will look like, and it could make this a high-growth stock by the end of 2026. In this video, I explain why this launch is so exciting.

*Stock prices used were end-of-day prices of March 18, 2026. The video was published on March 20, 2026.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin